Compare Nvidia Corp (NVDA) vs Teladoc Health Inc (TDOC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nvidia Corp vs Teladoc Health Inc — how do they compare? Nvidia Corp trades at $229.28 (market cap $5.57T), while Teladoc Health Inc trades at $5.77 (market cap $1.01B). The key difference: Nvidia Corp is far larger — about 5514.9× Teladoc Health Inc's market cap, and Nvidia Corp pays a 0.43% dividend while Teladoc Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Nvidia Corp for 115 Days and Teladoc Health Inc for 39 Days on average.
| NVDA | TDOC | |
|---|---|---|
Market Cap | $5.57T | $1.01B |
Volume | 117,720,595 | 4,668,477 |
Sector | Technology | Health |
52-Week High | $239.27 | $9.72 |
52-Week Low | $165.17 | $4.47 |
Typical Hold Time | 115 Days | 39 Days |
Enterprise Value | $5.54T | $1.27B |
Dividend Yield | 0.43% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NVIDIA (NVDA) trades at $230.48, down 2.9% on the day, with strong technical support at $228 and resistance at $235. The company demonstrates exceptional fundamental strength with 2025 revenue of $130.5B and net income of $72.9B, achieving a 55.84% profit margin. Recent quarterly earnings have consistently beaten expectations, with Q2 2026 EPS of $2.22 exceeding the $2.09 forecast. Analyst consensus remains strongly bullish with a $339.17 price target representing 47% upside potential from current levels.
NVIDIA's AI leadership and accelerating revenue growth position it for continued outperformance, though investors face risks from increased competition and market volatility. The stock's current valuation metrics (P/E 29.14, P/S 18.56) reflect premium pricing justified by exceptional profitability and market dominance in AI infrastructure. Institutional sentiment remains positive despite recent profit-taking by some funds.
TDOC trades at $5.54, down 0.36% on the day, with a bearish technical signal and mixed earnings history. The company reported revenue of $2.53B in 2025 but a net loss of $200.32M, reflecting ongoing profitability challenges. Analyst consensus is a 'Hold' with a $8.83 price target, indicating potential upside. Recent news includes a CFO transition and legal investigations, adding to investor uncertainty.
The outlook remains cautious due to persistent losses and competitive pressures, though valuation metrics like P/S of 0.4 and EV/EBITDA of 5.89 suggest the stock is undervalued. Key risks include weak cash flow trends and BetterHelp segment volatility. Upside depends on execution in integrated care and cost management.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nvidia Corp
NVIDIA Corporation designs, develops, and markets three dimensional (3D) graphics processors and related software. The Company offers products that provides interactive 3D graphics to the mainstream personal computer market.
Read more on NVDA →About Teladoc Health Inc
Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members.
Read more on TDOC →
